Download the New Oncology Research Brief from Precision Health Economics

How is value defined in cancer care? What do patients value most?

As healthcare spending continues to rise, payers and providers struggle to accurately measure value to patients, and with health systems all over the world shifting towards paying for value, not just volume, these efforts have never been more important.

Learn about PHE’s groundbreaking studies that have helped define the value of new oncology drugs, and why a variety of global stakeholders have turned to PHE to assist them in defining value in cancer care.

Download the free research brief, Innovations in Cancer Care: Capturing What Patients Value in the Calculus of Drug Costs, from Precision Health Economics.

It will make you rethink how value is being defined in the ongoing fight against cancer.

Get the brief

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.